Method and kit for in vitro prognosis or prediction of respuestapor of rheumatoid arthritis patients to treatment with TNFalpha factor blocking agents.

摘要

Method and kit for in vitro prognosis or prediction of the response from rheumatoid arthritis patients to treatment with TNF blockers factor alpha.; An in vitro method and kit for prognosis or prediction of response to treatment with TNF blocking agents alpha factor from patients with rheumatoid arthritis, comprising determining in a blood sample of said patient the expression level of at least one of the eight genes selected from the group: HLA-DRB3, eat2, GNLY, CAMP, SLC2A3, IL2RB, MXD4 and TLR5 or combinations thereof and comparing said expression level with respect to the expression values ​​obtained from patients treatment responders and nonresponders to it.